CN104666651A - Agent for treating cervical hypertrophy - Google Patents
Agent for treating cervical hypertrophy Download PDFInfo
- Publication number
- CN104666651A CN104666651A CN201510063401.6A CN201510063401A CN104666651A CN 104666651 A CN104666651 A CN 104666651A CN 201510063401 A CN201510063401 A CN 201510063401A CN 104666651 A CN104666651 A CN 104666651A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- folium
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010020880 Hypertrophy Diseases 0.000 title claims abstract description 21
- 241000218176 Corydalis Species 0.000 claims abstract description 12
- 241000812317 Selaginella delicatula Species 0.000 claims abstract description 12
- 241000775848 Syringa oblata Species 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 9
- 239000003814 drug Substances 0.000 claims description 30
- 240000009005 Calendula arvensis Species 0.000 claims description 11
- 235000007864 Calendula arvensis Nutrition 0.000 claims description 11
- 241000196324 Embryophyta Species 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 11
- 239000004576 sand Substances 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 11
- 239000000829 suppository Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 4
- 239000007919 dispersible tablet Substances 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 4
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 abstract 1
- 241000157282 Aesculus Species 0.000 abstract 1
- 241000123846 Buddleja officinalis Species 0.000 abstract 1
- 235000003880 Calendula Nutrition 0.000 abstract 1
- 240000001432 Calendula officinalis Species 0.000 abstract 1
- 241000931705 Cicada Species 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 241001127718 Etlingera Species 0.000 abstract 1
- 241000208367 Euonymus Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 235000016915 Ilex serrata Nutrition 0.000 abstract 1
- 241000594056 Ilex serrata Species 0.000 abstract 1
- 244000283207 Indigofera tinctoria Species 0.000 abstract 1
- 235000003990 Monochoria hastata Nutrition 0.000 abstract 1
- 240000000178 Monochoria vaginalis Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000155660 Phtheirospermum japonicum Species 0.000 abstract 1
- 241000222350 Pleurotus Species 0.000 abstract 1
- 241000612118 Samolus valerandi Species 0.000 abstract 1
- 241001247808 Stylophorum lasiocarpum Species 0.000 abstract 1
- 244000234281 Tamarix gallica Species 0.000 abstract 1
- 235000014265 Tamarix gallica Nutrition 0.000 abstract 1
- 240000003603 Woodfordia fruticosa Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000010181 horse chestnut Nutrition 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 231100001274 therapeutic index Toxicity 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229960005053 tinidazole Drugs 0.000 description 2
- 241000606161 Chlamydia Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 208000022555 Genital disease Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000005963 oophoritis Diseases 0.000 description 1
- 208000015124 ovarian disease Diseases 0.000 description 1
- 201000004535 ovarian dysfunction Diseases 0.000 description 1
- 231100000543 ovarian dysfunction Toxicity 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- ACZKMKGNTMOPBD-UHFFFAOYSA-N policresulen Chemical class CC1=CC(O)=C(S(O)(=O)=O)C=C1CC1=CC(S(O)(=O)=O)=C(O)C(CC=2C(=CC(O)=C(C=2)S(O)(=O)=O)C)=C1C ACZKMKGNTMOPBD-UHFFFAOYSA-N 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an agent for treating cervical hypertrophy. The agent is prepared from the following materials in parts by weight: 1-10 parts of stylophorum lasiocarpum, 10-20 parts of selaginella delicatula, 10-20 parts of root of common peony, 1-10 parts of liquorice root, 10-20 parts of bunge corydalis herb, 1-10 parts of medicinal cyathula root, 1-10 parts of morinda officinalis, 10-20 parts of tengyuch euonymus bark, 1-10 parts of periostracum cicada, 10-20 parts of etlingera yunnanense, 1-10 parts of ilex serrata, 10-20 parts of phtheirospermum japonicum, 1-10 parts of korsakow's monochoria, 10-20 parts of buddleia officinalis maxim, 1-10 parts of calendula root, 5-15 parts of tamarix chinensis, 1-10 parts of fruit of indigo plant, 5-15 parts of syringa oblata lindl, 10-20 parts of woodfordia fruticosa, 1-10 parts of Chinese buckeye seeds and 10-20 parts of pleurotus albellus. The agent disclosed by the invention has a significant effect on treatment of cervical hypertrophy, and is worthy of clinical application and popularization.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of cervical hypertrophy.
Background technology
Cervical hypertrophy is due to pathogenic infection cervical mucosals such as mycoplasma, chlamydia, antibacterial, viruses, such that cervix uteri is congested, edema, caused by cervix gland and interstitial generation hypertrophy.Uterine cavity blood stasis, ovarian dysfunction also can cause cervical hypertrophy.Its main clinic symptoms comprises that vaginal secretions increases, waist and sacrum pain, lower abdomen pendant rises, sexual life is hemorrhage.Delay the state of an illness or malpractice possibility up concurrent endometritis, fallopian tube adhesion, oophoritis etc., severe patient can cause sterility and infertility or cervical cancer, affects normal physiological period and family life.
Doctor trained in Western medicine takes Drug therapy or naturopathy for the treatment of cervical hypertrophy more.Drug therapy gives antibiotic medicine more, such as Compound Tinidazole medicine film and policresulen class medicine etc.; Naturopathy comprises electricity and presses treatment, cold therapy, laser therapy, micro-wave therapeutic etc.The former easily causes the side effect such as drug resistance, hepar damnification, and latter needs special instrument and equipment and professional operator, and may cause that cervical canal is narrow after treatment, adhesion etc.And the traditional Chinese medical science is mainly through determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, imposes the therapies such as invigorating the spleen and benefiting QI, nourishing kidney yin, clearing away heat-damp and promoting diuresis more, and have no side effect, compare doctor trained in Western medicine more safe and reliable.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of cervical hypertrophy.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of cervical hypertrophy, it is made up of the material of following weight portion: Herba Stylophori Lasiocapi 1-10 part, selaginella delicatula Alston 10-20 part, Radix Paeoniae Rubra 10-20 part, Radix Glycyrrhizae 1-10 part, Herba Corydalis Bungeanae 10-20 part, Radix Cyathulae 1-10 part, Radix Morindae Officinalis 1-10 part, Cortex toonae sinensis radicis 10-20 part, Periostracum Cicadae 1-10 part, sand Fructus Foeniculi 10-20 part, Folium ilicis serratae 1-10 part, Herba Phtheirospermi Japonici 10-20 part, Herba Monochoriae Korsakowii 1-10 part, close flowers and plants 10-20 part, Calendula arvensis L. 1-10 part, Ramulus et Folium Tamaricis 5-15 part, Fructus polygoni tinctorii 1-10 part, Syringa oblata Lindl. 5-15 part, Flos Woodfordiae Fruticosae 10-20 part, Semen Aesculi 1-10 part, Herba Parnassiae foliosae 10-20 part.
Preferably, the medicament for the treatment of cervical hypertrophy of the present invention is made up of the material of following weight portion: Herba Stylophori Lasiocapi 8 parts, selaginella delicatula Alston 15 parts, Radix Paeoniae Rubra 15 parts, 8 parts, Radix Glycyrrhizae, Herba Corydalis Bungeanae 15 parts, Radix Cyathulae 6 parts, Radix Morindae Officinalis 5 parts, Cortex toonae sinensis radicis 15 parts, Periostracum Cicadae 8 parts, 15 parts, sand Fructus Foeniculi, Folium ilicis serratae 5 parts, Herba Phtheirospermi Japonici 12 parts, Herba Monochoriae Korsakowii 6 parts, close flowers and plants 12 parts, Calendula arvensis L. 10 parts, Ramulus et Folium Tamaricis 10 parts, Fructus polygoni tinctorii 5 parts, Syringa oblata Lindl. 10 parts, Flos Woodfordiae Fruticosae 15 parts, Semen Aesculi 8 parts, Herba Parnassiae foliosae 12 parts.
More preferably, described medicament can be tablet, dispersible tablet, capsule, soft capsule, ointment or suppository.
The present invention also provides the purposes of compositions in the medicine of preparation treatment cervical hypertrophy, described compositions is made up of the material of following weight portion: Herba Stylophori Lasiocapi 1-10 part, selaginella delicatula Alston 10-20 part, Radix Paeoniae Rubra 10-20 part, Radix Glycyrrhizae 1-10 part, Herba Corydalis Bungeanae 10-20 part, Radix Cyathulae 1-10 part, Radix Morindae Officinalis 1-10 part, Cortex toonae sinensis radicis 10-20 part, Periostracum Cicadae 1-10 part, sand Fructus Foeniculi 10-20 part, Folium ilicis serratae 1-10 part, Herba Phtheirospermi Japonici 10-20 part, Herba Monochoriae Korsakowii 1-10 part, close flowers and plants 10-20 part, Calendula arvensis L. 1-10 part, Ramulus et Folium Tamaricis 5-15 part, Fructus polygoni tinctorii 1-10 part, Syringa oblata Lindl. 5-15 part, Flos Woodfordiae Fruticosae 10-20 part, Semen Aesculi 1-10 part, Herba Parnassiae foliosae 10-20 part.
Preferably, described compositions is made up of the material of following weight portion: Herba Stylophori Lasiocapi 8 parts, selaginella delicatula Alston 15 parts, Radix Paeoniae Rubra 15 parts, 8 parts, Radix Glycyrrhizae, Herba Corydalis Bungeanae 15 parts, Radix Cyathulae 6 parts, Radix Morindae Officinalis 5 parts, Cortex toonae sinensis radicis 15 parts, Periostracum Cicadae 8 parts, 15 parts, sand Fructus Foeniculi, Folium ilicis serratae 5 parts, Herba Phtheirospermi Japonici 12 parts, Herba Monochoriae Korsakowii 6 parts, close flowers and plants 12 parts, Calendula arvensis L. 10 parts, Ramulus et Folium Tamaricis 10 parts, Fructus polygoni tinctorii 5 parts, Syringa oblata Lindl. 10 parts, Flos Woodfordiae Fruticosae 15 parts, Semen Aesculi 8 parts, Herba Parnassiae foliosae 12 parts.
More preferably, described medicine can be tablet, dispersible tablet, capsule, soft capsule, ointment or suppository.
In the present compositions, selaginella delicatula Alston, Herba Parnassiae foliosae, Fructus polygoni tinctorii are monarch drug; Herba Stylophori Lasiocapi, Radix Paeoniae Rubra, Herba Corydalis Bungeanae, Radix Morindae Officinalis, Cortex toonae sinensis radicis, sand Fructus Foeniculi, Syringa oblata Lindl. are ministerial drug; Radix Cyathulae, Periostracum Cicadae, Folium ilicis serratae, Herba Phtheirospermi Japonici, Herba Monochoriae Korsakowii, close flowers and plants, Calendula arvensis L., Ramulus et Folium Tamaricis, Flos Woodfordiae Fruticosae, Semen Aesculi are adjuvant drug; Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, for making medicine.
Medicament of the present invention is turbid based on dampnessization, resolving depression of regulating the flow of vital energy, be aided with heat-clearing and toxic substances removing, QI invigorating invigorating middle warmer, spleen reinforcing is soothing the liver, removing dampness leukorrhagia stopping, eliminating evil dehumidifying, warming the meridian can warm up liver, and have effect of certain sterilizing and itch-relieving, treatment cervical hypertrophy Be very effective, clinic application and popularization.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modification that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
The preparation of embodiment medicament of the present invention
For suppository, the step of preparation process of medicament of the present invention is as follows:
(1) Herba Stylophori Lasiocapi 80 grams, selaginella delicatula Alston 150 grams, Radix Paeoniae Rubra 150 grams, 80 grams, Radix Glycyrrhizae, Herba Corydalis Bungeanae 150 grams, Radix Cyathulae 60 grams, Radix Morindae Officinalis 50 grams, Cortex toonae sinensis radicis 150 grams, Periostracum Cicadae 80 grams, 150 grams, sand Fructus Foeniculi, Folium ilicis serratae 50 grams, Herba Phtheirospermi Japonici 120 grams, Herba Monochoriae Korsakowii 60 grams, close flowers and plants 120 grams, Calendula arvensis L. 100 grams, Ramulus et Folium Tamaricis 100 grams, Fructus polygoni tinctorii 50 grams, Syringa oblata Lindl. 100 grams, Flos Woodfordiae Fruticosae 150 grams, Semen Aesculi 80 grams, Herba Parnassiae foliosae 120 grams is taken;
(2) Herba Parnassiae foliosae, Radix Cyathulae, Ramulus et Folium Tamaricis are broken into smalls, cross 120 mesh sieves, for subsequent use;
(3) Herba Stylophori Lasiocapi, Radix Paeoniae Rubra, Radix Glycyrrhizae, selaginella delicatula Alston, Herba Corydalis Bungeanae, Folium ilicis serratae, Periostracum Cicadae, sand Fructus Foeniculi, Herba Monochoriae Korsakowii, Calendula arvensis L., Syringa oblata Lindl., Flos Woodfordiae Fruticosae, Radix Morindae Officinalis, Cortex toonae sinensis radicis, Herba Phtheirospermi Japonici, close flowers and plants, Fructus polygoni tinctorii, Semen Aesculi are put into container to add water 10 liters and soak 10 hours, then heat 3 hours under the condition of backflow, filter, make filtrate evaporate to dryness, pulverize;
(4) combining step (2) and (3) gains, add in the oleum sapii substrate of 500 grams, heating and melting, fully stir evenly, in impouring mould, mould is first coated with one deck lubricant, lubricant is the alcohol mixeding liquid of glycerol and concentration expressed in percentage by volume 95%, mixed proportion is the ethanol of 95% of 1g glycerol: 5ml, after cooling, to prune spilling part with cutter, opening mold, released by suppository, packaging, obtains required drug suppository.Obtained 100 suppositorys.
The effect of experimental example pharmaceutical treatment cervical hypertrophy of the present invention
1, physical data selects cervical hypertrophy patient 80 example, is divided into observation group 50 example and matched group 30 example.Observation group's patient age between 21-48 year, 35.6 years old mean age; Matched group patient age between 20-45 year, 32.5 years old mean age.All patients all get rid of cervical cancer, acute genital disease and systemic disease.According to table 1, symptom score is carried out to two groups of patients, wherein average 6.24 ± 1.58 points of observation group, average 5.92 ± 1.87 points of matched group before treatment.Through t check analysis, the age of two groups of patients and symptom score there are no significant difference (p>0.05).
Table 1 Symptoms index
2,3-7 days after method clean period, cleans pudendum before sleeping every night.The auxiliary drug delivery instrument of observation group's use or 1 suppository of the present invention utilizing sanitary finger-cot for holding embodiment to be prepared are delivered to vagina depths, 1 times/day.Matched group uses tinidazole suppositories (Zhengzhou Yonghe Pharmaceutical Co), 1 times/day.Within continuous 7 days, be a course for the treatment of, 2 totally 14 days courses for the treatment of of medication, period prohibitive life.
3, after 2 courses for the treatment of of evaluation index, again carry out symptom score according to table 1, and calculate therapeutic index and effective percentage.
Recovery from illness: therapeutic index >=90%; Effective: therapeutic index is 60%-89%; Take a turn for the better: therapeutic index is 20%-59%; Invalid: therapeutic index < 20%.Wherein:
Score value × 100% before therapeutic index=(before treatment the rear score value of score value-treatment)/treatment
Effective percentage=(cure+effective+take a turn for the better) number of cases/total number of cases × 100%
4, statistical method adopts statistics software SPSS17.0 to carry out data analysis.Measurement data with
represent, adopt t inspection; Enumeration data adopts x
2inspection.With P < 0.05 for difference has statistical significance.
5, result
After treatment, observation group's symptom score is 1.02 ± 0.95 points, and matched group symptom score is 2.50 ± 1.96 points, through t check analysis, two groups have significant difference.This shows that observation group's symptom takes a turn for the better and is better than matched group, and medicament of the present invention has significant advantage in treatment cervical hypertrophy.
Table 2 is below shown in two groups of efficient interpretations of result.Through x
2inspection, the effective percentage of two groups of patients after treatment has significant difference.
A table 2 liang group effective percentage compares
Note: compare with matched group, * p<0.05
Claims (6)
1. treat the medicament of cervical hypertrophy for one kind, it is characterized in that being made up of the material of following weight portion: Herba Stylophori Lasiocapi 1-10 part, selaginella delicatula Alston 10-20 part, Radix Paeoniae Rubra 10-20 part, Radix Glycyrrhizae 1-10 part, Herba Corydalis Bungeanae 10-20 part, Radix Cyathulae 1-10 part, Radix Morindae Officinalis 1-10 part, Cortex toonae sinensis radicis 10-20 part, Periostracum Cicadae 1-10 part, sand Fructus Foeniculi 10-20 part, Folium ilicis serratae 1-10 part, Herba Phtheirospermi Japonici 10-20 part, Herba Monochoriae Korsakowii 1-10 part, close flowers and plants 10-20 part, Calendula arvensis L. 1-10 part, Ramulus et Folium Tamaricis 5-15 part, Fructus polygoni tinctorii 1-10 part, Syringa oblata Lindl. 5-15 part, Flos Woodfordiae Fruticosae 10-20 part, Semen Aesculi 1-10 part, Herba Parnassiae foliosae 10-20 part.
2. the medicament for the treatment of cervical hypertrophy according to claim 1, it is made up of the material of following weight portion: Herba Stylophori Lasiocapi 8 parts, selaginella delicatula Alston 15 parts, Radix Paeoniae Rubra 15 parts, 8 parts, Radix Glycyrrhizae, Herba Corydalis Bungeanae 15 parts, Radix Cyathulae 6 parts, Radix Morindae Officinalis 5 parts, Cortex toonae sinensis radicis 15 parts, Periostracum Cicadae 8 parts, 15 parts, sand Fructus Foeniculi, Folium ilicis serratae 5 parts, Herba Phtheirospermi Japonici 12 parts, Herba Monochoriae Korsakowii 6 parts, close flowers and plants 12 parts, Calendula arvensis L. 10 parts, Ramulus et Folium Tamaricis 10 parts, Fructus polygoni tinctorii 5 parts, Syringa oblata Lindl. 10 parts, Flos Woodfordiae Fruticosae 15 parts, Semen Aesculi 8 parts, Herba Parnassiae foliosae 12 parts.
3. the medicament for the treatment of cervical hypertrophy according to claim 1 and 2, wherein said medicament can be tablet, dispersible tablet, capsule, soft capsule, ointment or suppository.
4. the purposes of compositions in the medicine of preparation treatment cervical hypertrophy, it is characterized in that described compositions is made up of the material of following weight portion: Herba Stylophori Lasiocapi 1-10 part, selaginella delicatula Alston 10-20 part, Radix Paeoniae Rubra 10-20 part, Radix Glycyrrhizae 1-10 part, Herba Corydalis Bungeanae 10-20 part, Radix Cyathulae 1-10 part, Radix Morindae Officinalis 1-10 part, Cortex toonae sinensis radicis 10-20 part, Periostracum Cicadae 1-10 part, sand Fructus Foeniculi 10-20 part, Folium ilicis serratae 1-10 part, Herba Phtheirospermi Japonici 10-20 part, Herba Monochoriae Korsakowii 1-10 part, close flowers and plants 10-20 part, Calendula arvensis L. 1-10 part, Ramulus et Folium Tamaricis 5-15 part, Fructus polygoni tinctorii 1-10 part, Syringa oblata Lindl. 5-15 part, Flos Woodfordiae Fruticosae 10-20 part, Semen Aesculi 1-10 part, Herba Parnassiae foliosae 10-20 part.
5. purposes according to claim 4, wherein said compositions is made up of the material of following weight portion: Herba Stylophori Lasiocapi 8 parts, selaginella delicatula Alston 15 parts, Radix Paeoniae Rubra 15 parts, 8 parts, Radix Glycyrrhizae, Herba Corydalis Bungeanae 15 parts, Radix Cyathulae 6 parts, Radix Morindae Officinalis 5 parts, Cortex toonae sinensis radicis 15 parts, Periostracum Cicadae 8 parts, 15 parts, sand Fructus Foeniculi, Folium ilicis serratae 5 parts, Herba Phtheirospermi Japonici 12 parts, Herba Monochoriae Korsakowii 6 parts, close flowers and plants 12 parts, Calendula arvensis L. 10 parts, Ramulus et Folium Tamaricis 10 parts, Fructus polygoni tinctorii 5 parts, Syringa oblata Lindl. 10 parts, Flos Woodfordiae Fruticosae 15 parts, Semen Aesculi 8 parts, Herba Parnassiae foliosae 12 parts.
6. the purposes according to claim 4 or 5, wherein said medicine can be tablet, dispersible tablet, capsule, soft capsule, ointment or suppository.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510481410.7A CN104983954A (en) | 2015-02-06 | 2015-02-06 | Medicament for treating cervical hypertrophy |
| CN201510063401.6A CN104666651B (en) | 2015-02-06 | 2015-02-06 | A kind of medicament for the treatment of cervical hypertrophy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510063401.6A CN104666651B (en) | 2015-02-06 | 2015-02-06 | A kind of medicament for the treatment of cervical hypertrophy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510481410.7A Division CN104983954A (en) | 2015-02-06 | 2015-02-06 | Medicament for treating cervical hypertrophy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104666651A true CN104666651A (en) | 2015-06-03 |
| CN104666651B CN104666651B (en) | 2015-10-14 |
Family
ID=53302587
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510063401.6A Expired - Fee Related CN104666651B (en) | 2015-02-06 | 2015-02-06 | A kind of medicament for the treatment of cervical hypertrophy |
| CN201510481410.7A Pending CN104983954A (en) | 2015-02-06 | 2015-02-06 | Medicament for treating cervical hypertrophy |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510481410.7A Pending CN104983954A (en) | 2015-02-06 | 2015-02-06 | Medicament for treating cervical hypertrophy |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN104666651B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110302304A (en) * | 2019-08-12 | 2019-10-08 | 南京依美生物科技有限公司 | A kind of gynecological gel preparation and preparation method thereof for treating cervical hypertrophy |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101791377A (en) * | 2010-04-12 | 2010-08-04 | 汤永顺 | Traditional Chinese medicine preparation for post-operation rehabilitation of cervicitis and cervical hypertrophy |
-
2015
- 2015-02-06 CN CN201510063401.6A patent/CN104666651B/en not_active Expired - Fee Related
- 2015-02-06 CN CN201510481410.7A patent/CN104983954A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101791377A (en) * | 2010-04-12 | 2010-08-04 | 汤永顺 | Traditional Chinese medicine preparation for post-operation rehabilitation of cervicitis and cervical hypertrophy |
Non-Patent Citations (1)
| Title |
|---|
| 许文学等: "中医治疗癌前病变专题讲座(十)-宫颈炎", 《中国中医药现代远程教育》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104666651B (en) | 2015-10-14 |
| CN104983954A (en) | 2015-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105535715A (en) | Traditional Chinese medicine skin-wash liquid for treating hot and damp eczema | |
| CN101011544A (en) | Gout rapid recovery pill(capsule) and preparation technique thereof | |
| CN102743665B (en) | Chinese medicinal composition for promoting healing after boneblast, as well as preparation method and application thereof | |
| CN102961483B (en) | Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof | |
| CN103463582B (en) | A kind of pharmaceutical composition treating pelvic inflammatory disease and its production and use | |
| CN104666651B (en) | A kind of medicament for the treatment of cervical hypertrophy | |
| CN102579677B (en) | Chinese medicinal composition for treating brain glioma | |
| CN103705846A (en) | Traditional Chinese medicine preparation for treating ovarian cyst | |
| CN103611027B (en) | The pharmaceutical composition of a kind of clinical prevention, nursing and treatment trichomonal vaginitis | |
| CN102973876B (en) | Drug for treating pathological leukorrhagia | |
| CN101637599B (en) | Chinese medicinal composition for removing haemostasis in female genital system | |
| CN105770400A (en) | Traditional Chinese medicine composition for treating puerperal infection | |
| CN110841043A (en) | Traditional Chinese medicine composition of fallopian tube infertility plaster | |
| CN104274617A (en) | Traditional Chinese medicine composition for nursing treatment of acute cervicitis | |
| CN103520424A (en) | Traditional Chinese medicine preparation for treating periodontitis | |
| CN103830679B (en) | A kind of medicine and application thereof for the treatment of irritable bowel syndrome | |
| CN1279953C (en) | Mediciation for curing female disease | |
| CN102366591B (en) | Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method | |
| CN106038905A (en) | Narcotic analgesic and preparation method thereof | |
| CN105535674A (en) | A medicine for treating chronic cervicitis | |
| CN1424095A (en) | Analgestic plaster | |
| CN105055702A (en) | Pharmaceutical preparation for treating chronic pelvic inflammatory disease | |
| CN104758627B (en) | It is a kind of to treat the Chinese medicine preparation for not producing type chronic cervicitis | |
| CN102512637B (en) | Medicine for treating special chronic sinusitis of patients | |
| CN1515307A (en) | Medicine for curing hysteromyoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: CHEN QI Free format text: FORMER OWNER: LI ZHIGANG Effective date: 20150906 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Qi Inventor before: Li Zhigang |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI ZHIGANG TO: CHEN QI |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150906 Address after: 273500 Shandong city of Jining province Zoucheng City 1000 Road No. 1 city people's Hospital of Obstetrics and Gynecology Applicant after: Chen Qi Address before: 054001 Xingtai Development Zone, Hebei, South Road, No. 168 Applicant before: Li Zhigang |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151014 Termination date: 20170206 |